There's still plenty of upside here, but those who bought originally for Fonda revenues giving great returns in earnings per share due to the small number of shares on issue, have had a spanner thrown in the works with this dilution.
Was a no brainer based on Fonda alone. Now holders are relying on HA to bring home the bacon. So risks are higher.
Chopping out the 2nd tranche will really help in this regard though.
Still really positive on the stock overall.
JIMO
Add to My Watchlist
What is My Watchlist?